Redefining the Diagnostic Threshold for Breast Cancer-related Lymphedema

Area of Science:

• Oncology
• Lymphedema Research
• Surgical Outcomes

Background:

• Breast cancer-related lymphedema (BCRL) is a common complication of breast cancer treatment.
• Current diagnostic thresholds for BCRL are inconsistent and lack robust validation.
• The standard 10% interlimb volume difference may lead to underdiagnosis.

Purpose of the Study:

• To establish a normative, distribution-based threshold for diagnosing BCRL.
• To compare the diagnostic accuracy of the proposed threshold with the conventional 10% criterion.

Main Methods:

• Prospective cohort study of 858 female breast cancer patients.
• Analysis of preoperative bilateral limb measurements to derive a normative threshold.
• Comparison of a 7.5% threshold (2 SD above mean) versus 10% in 167 patients post-axillary lymph node dissection.

Main Results:

• Preoperative interlimb volume differences were normally distributed (mean 0.24%, SD 3.74%), supporting a 7.5% threshold.
• The 7.5% threshold identified 43.1% of patients, compared to 31.7% with the 10% threshold, an increase of 11.4% (P<0.001).
• Of patients meeting the 7.5% threshold, 94.4% reported symptoms or used compression garments.

Conclusions:

• A 7.5% interlimb volume difference threshold improves the identification of clinically significant BCRL.
• This empirically validated threshold enhances early detection and intervention for BCRL.
• Adoption of the 7.5% threshold may lead to improved patient outcomes in breast cancer survivors.